Identification of potential therapeutic target of naringenin in breast cancer stem cells inhibition by bioinformatics and in vitro studies

• Main Authors: Adam Hermawan (Author), Muthi Ikawati (Author), Riris Istighfari Jenie (Author), Annisa Khumaira (Author), Herwandhani Putri (Author), Ika Putri Nurhayati (Author), Sonia Meta Angraini (Author), Haruma Anggraini Muflikhasari (Author)
• Format: Book
• Published: Elsevier, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Cancer therapy is a strategic measure in inhibiting breast cancer stem cell (BCSC) pathways. Naringenin, a citrus flavonoid, was found to increase breast cancer cells' sensitivity to chemotherapeutic agents. Bioinformatics study and 3D tumorsphere in vitro modeling in breast cancer (mammosphere...